1. Arnone D., Saraykar S., Salem H., Teixeira A.L., Dantzer R., SelvarajS.: Role of kynurenine pathway and its metabolites in mooddisorders: A systematic review and meta-analysis of clinical studies.Neurosci. Biobehav. Rev., 2018; 92: 477–485
2. Badawy A.A.: Hypothesis kynurenic and quinolinic acids: Themain players of the kynurenine pathway and opponents in inflammatorydisease. Med. Hypotheses, 2018; 118: 129–138
3. Badawy A.A.: Kynurenine pathway of tryptophan metabolism:Regulatory and functional aspects. Int. J. Tryptophan Res., 2017;10: 1178646917691938 4 Bieliński M., Jaracz M., Lesiewska N., Tomaszewska M., SikoraM., Junik R., Kamińska A., Tretyn A., Borkowska A.: Associationbetween COMT Val158Met and DAT1 polymorphisms and depressivesymptoms in the obese population. Neuropsychiatr. Dis. Treat.,2017; 13: 2221–2229
4. Bieliński M., Jaracz M., Lesiewska N., Tomaszewska M., Sikora M., Junik R., Kamińska A., Tretyn A., Borkowska A.: Association between COMT Val158Met and DAT1 polymorphisms and depressive symptoms in the obese population. Neuropsychiatr. Dis. Treat., 2017; 13: 2221–2229
5. Bonaccorso S., Marino V., Biondi M., Grimaldi F., Ippoliti F.,Maes M.: Depression induced by treatment with interferon-alphain patients affected by hepatitis C virus. J. Affect. Disord., 2002;72: 237–241